Full Text View
Tabular View
No Study Results Posted
Related Studies
Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
This study is ongoing, but not recruiting participants.
Study NCT00942682   Information provided by Dana-Farber Cancer Institute
First Received: July 17, 2009   Last Updated: June 22, 2011   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)